logo
  

Morgan Stanley Investment Management Raises $3.1 Bln For North Haven Real Estate Fund X Global

Morgan Stanley Real Estate Investing, the private real estate investment arm of Morgan Stanley Investment Management, said Thursday that it has raised about $3.1 billion for North Haven Real Estate Fund X Global or "G10" or the "Fund". It exceeds its original fundraising target and surpassing the size of its predecessor fund, North Haven Real Estate Fund IX Global.

G10 investors include a sophisticated group of public and private pension funds, sovereign wealth funds, insurance companies, and individuals from around the world, with over 80% of the institutional capital representing commitments from existing North Haven Real Estate clients.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration (FDA) approved Boehringer Ingelheim's Cyltezo as the first interchangeable biosimilar to AbbVie's top-selling drug Humira or adalimumab. Cyltezo, originally approved in August 2017, is both biosimilar to, and interchangeable with Humira for Cyltezo's approved uses. The Food and Drug Administration may be planning to allow people to receive Covid-19 vaccine booster shot that is different from the initial dose, reports indicate. The agency is likely to make the announcement on mix and match approach on coronavirus booster vaccines on Wednesday. The move will be part of FDA's expected authorization of boosters for the Moderna and Johnson & Johnson vaccines. Drug major Johnson & Johnson on Tuesday raised again its forecast for fiscal 2021 earnings and sales, which are above market view, after reporting higher results in the third quarter. The company's quarterly adjusted earnings also beat market estimates. In pre-market activity on the NYSE, JNJ shares were gaining around 1.24 percent to trade at $162.10.
Follow RTT